Ambrx Biopharma Cayman, Inc. Common Stock, Value, Issued USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Common Stock, Value, Issued history and growth rate from 2020 to 2023.
  • Ambrx Biopharma Cayman, Inc. Common Stock, Value, Issued for the quarter ending June 30, 2023 was $43 K, a 59.3% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $43 K +$16 K +59.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $39 K Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $27 K $0 0% Dec 31, 2022 10-Q 2023-08-09
Q2 2022 $27 K Jun 30, 2022 6-K 2022-08-29
Q4 2021 $27 K +$27 K Dec 31, 2021 10-K 2023-03-30
Q4 2020 $0 Dec 31, 2020 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.